BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 11848506)

  • 1. Synergistic cytotoxic action of vitamin C and vitamin K3.
    Zhang W; Negoro T; Satoh K; Jiang Y; Hashimoto K; Kikuchi H; Nishikawa H; Miyata T; Yamamoto Y; Nakano K; Yasumoto E; Nakayachi T; Mineno K; Satoh T; Sakagami H
    Anticancer Res; 2001; 21(5):3439-44. PubMed ID: 11848506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic activity of vitamins K1, K2 and K3 against human oral tumor cell lines.
    Okayasu H; Ishihara M; Satoh K; Sakagami H
    Anticancer Res; 2001; 21(4A):2387-92. PubMed ID: 11724297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of tumor-specific cytotoxicity and apoptosis by doxorubicin.
    Suzuki F; Hashimoto K; Kikuchi H; Nishikawa H; Matsumoto H; Shimada J; Kawase M; Sunaga K; Tsuda T; Satoh K; Sakagami H
    Anticancer Res; 2005; 25(2A):887-93. PubMed ID: 15868924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxic activity of styrylchromones against human tumor cell lines.
    Momoi K; Sugita Y; Ishihara M; Satoh K; Kikuchi H; Hashimoto K; Yokoe I; Nishikawa H; Fujisawa S; Sakagami H
    In Vivo; 2005; 19(1):157-63. PubMed ID: 15796168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-specific cytotoxicity and type of cell death induced by sodium 5,6-benzylidene-L-ascorbate.
    Kishino K; Hashimoto K; Amano O; Kochi M; Liu WK; Sakagami H
    Anticancer Res; 2008; 28(5A):2577-84. PubMed ID: 19035281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-specific cytotoxicity and type of cell death induced by gefitinib in oral squamous cell carcinoma cell lines.
    Chu Q; Amano O; Kanda Y; Kunii S; Wang Q; Sakagami H
    Anticancer Res; 2009 Dec; 29(12):5023-31. PubMed ID: 20044612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of non-apoptotic cell death by morphinone in human promyelocytic leukemia HL-60 cells.
    Takeuchi R; Hoshijima H; Nagasaka H; Chowdhury SA; Kikuchi H; Kanda Y; Kunii S; Kawase M; Sakagami H
    Anticancer Res; 2006; 26(5A):3343-8. PubMed ID: 17094451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re-evaluation of tumor-specific cytotoxicity of mitomycin C, bleomycin and peplomycin.
    Sasaki M; Okamura M; Ideo A; Shimada J; Suzuki F; Ishihara M; Kikuchi H; Kanda Y; Kunii S; Sakagami H
    Anticancer Res; 2006; 26(5A):3373-80. PubMed ID: 17094455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The in vitro antitumor activity of vitamins C and K3 against ovarian carcinoma.
    von Gruenigen VE; Jamison JM; Gilloteaux J; Lorimer HE; Summers M; Pollard RR; Gwin CA; Summers JL
    Anticancer Res; 2003; 23(4):3279-87. PubMed ID: 12926064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between dental metals and antioxidants, assessed by cytotoxicity assay and ESR spectroscopy.
    Kinoshita N; Yamamura T; Teranuma H; Katayama T; Tamanyu M; Negoro T; Satoh K; Sakagami H
    Anticancer Res; 2002; 22(6C):4017-22. PubMed ID: 12553026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-specificity and type of cell death induced by trihaloacetylazulenes in human tumor cell lines.
    Sekine T; Takahashi J; Nishishiro M; Arai A; Wakabayashi H; Kurihara T; Kobayashi M; Hashimoto K; Kikuchi H; Katayama T; Kanda Y; Kunii S; Motohashi N; Sakagami H
    Anticancer Res; 2007; 27(1A):133-43. PubMed ID: 17352225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-specific cytotoxicity and type of cell death induced by peplomycin in oral squamous cell carcinoma cell lines.
    Liu Y; Sakagami H; Amano O; Kikuchi H; Nakamura Y; Ishihara M; Kanda Y; Kunii S; Zhang W; Yu G
    Anticancer Res; 2008; 28(4B):2197-204. PubMed ID: 18751395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-cytotoxic activity relationships of simple hydroxylated coumarins.
    Kawase M; Sakagami H; Hashimoto K; Tani S; Hauer H; Chatterjee SS
    Anticancer Res; 2003; 23(4):3243-6. PubMed ID: 12926059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination effect of lignin F and natural products.
    Jiang Y; Satoh K; Aratsu C; Kobayashi N; Unten S; Kakuta H; Kikuchi H; Nishikawa H; Ochiai K; Sakagami H
    Anticancer Res; 2001; 21(2A):965-70. PubMed ID: 11396189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic activity of steroidal saponins against human oral tumor cell lines.
    Furuya S; Takayama F; Mimaki Y; Sashida Y; Satoh K; Sakagami H
    Anticancer Res; 2000; 20(6B):4189-94. PubMed ID: 11205247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-specific cytotoxicity of 3,5-dibenzoyl-1,4-dihydropyridines.
    Morshed SR; Hashimoto K; Murotani Y; Kawase M; Shah A; Satoh K; Kikuchi H; Nishikawa H; Maki J; Sakagami H
    Anticancer Res; 2005; 25(3B):2033-8. PubMed ID: 16158941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-specific cytotoxicity and apoptosis-inducing activity of berberines.
    Inoue K; Kulsum U; Chowdhury SA; Fujisawa S; Ishihara M; Yokoe I; Sakagami H
    Anticancer Res; 2005; 25(6B):4053-9. PubMed ID: 16309199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-specific cytotoxic activity and type of cell death induced by 4-trifluoromethylimidazoles in human oral squamous cell carcinoma cell lines.
    Takekawa F; Nagumo T; Shintani S; Hashimoto K; Kikuchi H; Katayama T; Ishihara M; Amano O; Kawase M; Sakagami H
    Anticancer Res; 2007; 27(6B):4065-9. PubMed ID: 18225572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxic activity of 2-aminomethylene-3(2H)-benzofuranones against human oral tumor cell lines.
    Terasawa K; Sugita Y; Yokoe I; Fujisawa S; Sakagami H
    Anticancer Res; 2001; 21(5):3371-5. PubMed ID: 11848496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor potential of three herbal extracts against human oral squamous cell lines.
    Chu Q; Satoh K; Kanamoto T; Terakubo S; Nakashima H; Wang Q; Sakagami H
    Anticancer Res; 2009 Aug; 29(8):3211-9. PubMed ID: 19661337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.